Successful Use of Pembrolizumab to Treat Refractory Thymic Carcinoma with High PD-L1 Expression

Thymic carcinoma is a relatively rare and aggressive thymic epithelial tumor. Herein, we report successful treatment of thymic carcinoma with pembrolizumab. A 68-year-old woman was admitted to our hospital for evaluation of chest pain. Chest computed tomography showed a mass in the anterior mediasti...

Descripción completa

Detalles Bibliográficos
Autores principales: Isshiki, Takuma, Isobe, Kazutoshi, Tochigi, Naobumi, Sunakawa, Motoko, Nakamura, Yasuhiko, Shibuya, Kazutoshi, Sakamoto, Susumu, Takai, Yujiro, Homma, Sakae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243955/
https://www.ncbi.nlm.nih.gov/pubmed/30483099
http://dx.doi.org/10.1159/000493187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243955/
https://www.ncbi.nlm.nih.gov/pubmed/30483099
http://dx.doi.org/10.1159/000493187

Ejemplares similares